A potential Covid-19 vaccine’s recording-breaking pace to clinical trial could become the new normal as researchers start looking for vaccines before new infections even break out.
The potential is there to break the decade-long timeline to develop new vaccines, making health professionals more nimble in the face of evolving threats. And it could have happened even sooner if the investment in studying SARS and MERS didn’t dry up when those outbreaks went away, scientists said.
The first clinical trial began March 16 for a candidate vaccine to guard against SARS-Cov-2, the novel coronavirus that causes Covid-19. An actual vaccine won’t ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.